Los nuevos anticoagulantes orales presentan mejor relación riesgobeneficio que la warfarina para la prevención de eventos cardioembólicos en pacientes con fibrilación auricular / New anticoagulants have better risk-benefit profile than warfarin for the prevention of embolic events in patients with atrial fibrillation
Evid. actual. práct. ambul
; 19(4): 110-110, 2016. tab
Article
in Spanish
| LILACS
| ID: biblio-1150598
Responsible library:
AR2.1
Full text:
Available
Collection:
International databases
Health context:
Sustainable Health Agenda for the Americas
/
SDG3 - Health and Well-Being
Health problem:
Goal 9: Noncommunicable diseases and mental health
/
Target 3.4: Reduce premature mortality due to noncommunicable diseases
Database:
LILACS
Main subject:
Atrial Fibrillation
/
Anticoagulants
Type of study:
Controlled clinical trial
/
Etiology study
/
Risk factors
/
Systematic review
Limits:
Humans
Language:
Spanish
Journal:
Evid. actual. práct. ambul
Journal subject:
Medicine
/
Delivery of Health Care
Year:
2016
Document type:
Article
Affiliation country:
Argentina
Institution/Affiliation country:
Hospital Italiano de Buenos Aires/AR